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ABSTRACT 
Disruption of the Temporal Activation of Ras EGFR-MAPK Axis by Targeting Critical 
Membrane Phospholipid Second Messenger 
 
Sergio David Cortes Acosta 
Department of Nutrition and Food Sciences 
Texas A&M University 
 
Research Advisor: Dr. Robert S. Chapkin 
Department of Nutrition and Food Sciences 
 
The Ras-EGFR-MAPK signaling axis is chronically up-regulated in colon cancer, and 
pharmacological inhibition of signaling through Ras and/or EGFR has been shown to prevent 
colon tumor formation.   Recent evidence suggests that production of the signaling lipid 
phosphatidic acid (PA) is essential for efficient Ras-EGFR-MAPK signaling.  With respect to 
cancer prevention, there is a growing body of experimental, epidemiological and preclinical 
evidence indicating that fish oil-containing diets rich in n-3 polyunsaturated fatty acids (PUFA), 
e.g., DHA and its metabolic precursor EPA, are protective against colon tumorigenesis.  We 
have demonstrated that DHA attenuates signaling of the Ras-EGFR-MAPK axis, however, the 
mechanism underlying this effect is not known. Therefore, we determined if the attenuation of 
Ras-EGFR signaling output by DHA is mediated via reduction of PA production.  For this 
purpose, the young adult mouse colonocyte (YAMC) cell model expressing a FRET biosensor 
capable of monitoring cellular levels of K-Ras activation was utilized in conjunction with 
fluorescence microscopy techniques to monitor temporal changes of activated K-Ras levels 
following growth factor stimulation.  Elucidating K-Ras as a molecular target of dietary 
bioactives is noteworthy because establishing a causal role of n-3 PUFA in colon cancer 
prevention would have a major translational impact due to their safety and tolerance. 
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CHAPTER I  
INTRODUCTION 
 
Many colorectal cancers contain KRas mutations, which confer resistance to standard therapy 
and have therefore been termed “undruggable”1,2.  Since no curative treatments for KRas driven 
colon cancer are available, there is a critical need to develop toxicologically innocuous KRas 
therapeutic approaches that are free of safety problems intrinsic to drugs administered over long 
periods of time.  One strategy for targeting oncogenic KRas driven cells, which has gained 
momentum recently, is to attenuate KRas activation3,4.  
 
There is a growing body of experimental, epidemiological and preclinical evidence indicating 
that fish oil-containing diets rich in n-3 PUFA, e.g., docosahexaenoic acid (DHA) and its 
metabolic precursor eicosapentaenoic acid (EPA), are protective against colon tumorigenesis5,6.  
Establishing a causal role of n-3 PUFA in colon cancer prevention would have a major 
translational impact because these dietary nutrients are safe and well tolerated7.  For example, 
human doses as high as 17.6 gram per day are free of toxicity8.   
 
Research in the Chapkin lab has determined that DHA reduces epidermal growth factor (EGF) 
stimulated Ras activation in vitro and in vivo9,10.  However, the mechanism underlying this 
attenuation has not been fully resolved.  The epidermal growth factor receptor (EGFR) is 
primarily localized to the plasma membrane11. Upon EGF stimulation, this receptor induces a 
signaling pathway that recruits certain proteins to the plasma membrane including the enzymes 
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Phospholipase D (PLD2) and Diacylglycerol Kinase (DGK). These two enzymes generate 
phosphatidic acid (PA)12.  
 
Following EGFR activation, the guanine exchange factor, SOS1, is subsequently recruited to the 
plasma membrane via the production of phosphatidic acid (PA), where it activates Ras13.  This 
triggers a chain reaction of signaling events that ultimately lead to cell survival14. Interestingly, 
EGFR signaling is up-regulated in many cancer cells, and the PA-generating enzymes, PLD and 
DGK are considered critical for proliferation, migration, and survival of cancer cells12.  
 
DHA is known to reduce the association of Ras with its guanine exchange factor, SOS115. DHA 
has also been shown to reduce levels of the signaling lipid, phosphatidylinositol 4,5-bisphosphate 
(PIP2)16.  Alterations to the spatiotemporal production of the signaling lipid PA is known to 
affect Ras signaling12.  Therefore, we proposed that DHA attenuates Ras activation by disrupting 
the spatiotemporal production of the critical signaling lipid, PA.	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CHAPTER II 
METHODS 
 
Cell culture 
Young Adult Mouse Colonocytes (YAMC cells) 
Young adult mouse colonocytes (YAMC) cells, conditionally immortalized colonocytes, were 
originally obtained from R.H. Whitehead, Ludwig Cancer Institute (Melbourne, Australia). 
YAMC cells (passages 12-17) were cultured under permissive conditions, 33° C and 5% CO2 in 
RPMI 1640 media (Mediatech, Manassas, VA) supplemented with 5% fetal bovine serum (FBS; 
Hyclone, Logan, UT), 2 mM GlutaMax (Gibco, Grand Island, NY), 5 µg/mL insulin, 5 µg/ml 
transferrin, 5 ng/ml selenious acid (Collaborative Bomedical Products, Bedford, MA), and 5 
IU/mL of murine interferon-γ (Roche, Mannheim, Germany). In select cultures, for the final 16-
18 h, complete media was replaced with low-serum (0.5% FBS) media. Cells were then 
stimulated with 0-25 ng/mL recombinant mouse epidermal growth factor EGF (Sigma, St. Louis, 
MO). 
 
Sw48 K-Ras G12D Cells (human cancer cells) 
The Sw-48 isogenic cell lines (human cancer cells) are the recently developed cell models to 
investigate endogenous isoform-specific Ras signaling in an identical genetic background. The 
model has been generated  using adeno-associated virus (AAV) somatic homologous 
recombination-based technology to directly modify endogenous Ras genes via introduction of 
activating mutations 17. A panel of isogenic Sw48 cell lines expressing oncogenically mutated K-
Ras variants (G12V, G12D, G13D) from the endogenous K-Ras locus has been developed and 
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used extensively. These K-Ras variants are chosen because one third of colorectal tumors harbor 
K-Ras mutations 18. Sw48 K-Ras G12D cells (passages 12-17) were cultured under permissive 
conditions, 37° C and 5% CO2 in RPMI 1640 media (Mediatech, Manassas, VA) supplemented 
with 10% fetal bovine serum (FBS; Hyclone, Logan, UT), 2 mM GlutaMax (Gibco, Grand 
Island, NY), 5 µg/mL insulin, 5 µg/ml transferrin, and 5 ng/ml selenious acid (Collaborative 
Bomedical Products, Bedford, MA). In select cultures, for the final 16-18 h, complete media was 
replaced with low-serum (0.5% FBS) media. Cells were then stimulated with 0-25 ng/mL 
epidermal growth factor EGF (Sigma, St. Louis, MO). 
 
Transfection 
Spo-20 GFP PA Probe 
YAMC cells and Sw48 K-Ras G12D cells were seeded and transfected with the a plasmid 
encoding for the Spo-20 GFP PA binding probe (Zhang, 2014). Transfection conditions were 
optimized to minimize the amount of DNA and lipofection reagent used to avoid nonspecific 
cytotoxicity. Prior to transfection, cells were seeded at a density of 25,000 cells/well into a Lab-
Tek (# 154461) two chamber slide of 4.0 cm2 /well. YAMC cells and Sw48 K-Ras G12D were 
transfected using 4 µL Lipofectamine 3000, 5µL P3000 reagent, 250 µL Opti-MEM Medium, 
and 2 µg DNA/well (Lipofectamin 3000 Reagent Protocol, Invitrogen, Life Technologies). 
Approximately 32 h after transfection, cells were incubated in low serum media (0.5% FBS) and 
then imaged 48 h after transfection. 
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Use of the Spo GFP PA probe 
The design of our study was based on previous working documenting the properties of the Spo 
GFP PA probe in EGF-stimulated HCC1806 breast cancer cells12.  HCC1806 breast cancer cell 
imaging results were taken into consideration and compared with YAMC and Sw48 GFP cells 
transfected with the Spo20 GFP PA probe and stimulated with EGF.  
 
K-Ras Raichu FRET Biosensor 
The plasmid encoding for the K-Ras domain targeted KRas-Raichu (Raichu-124x) biosensor 
(Mochizuki, 2001) was utilized. Transfection conditions were optimized to minimize the amount 
of DNA and lipofection reagent used to avoid nonspecific cytotoxicity. Prior to transfection, 
cells were seeded at a density of 25,000 cells/well into MatTek (Ashland, MA) glass bottom 
35mm dishes. Cells were transfected using 4 µL Lipofectamine 3000, 5µL P3000 reagent, 250 
µL Opti-MEM Medium, and 2 µg DNA (Lipofectamin 3000 Reagent Protocol, Invitrogen, Life 
Technologies). Approximately 32 h after transfection, cells were incubated in low serum media 
(0.5% FBS). Cells were imaged 48 h after transfection.  
 
PLD2 Inhibitor (FIPI) and Diacylglycerol Kinase Inhibitor R59949 (DGKi) 
The phosphpolipase D inhibitor 5-fluoro-2-indolyl-deschlorohalopemide (FIPI), and 
Diacylglycerol Kinase inhibitor R59949 (DGKi) have been described in previous studies12. 
YAMC cells were treated with PLD2 inhibitor (FIPI, 1uM) and/or the diacylglycerol kinase 
inhibitor (DGKi, 20uM). Cells were pretreated with these inhibitors 1 h before imaging.  
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Imaging and Quantification 
YAMC Cells – Spo-20 GFP PA Probe  
Young Adult Mouse Colonocytes were transfected at a density of 25,000 cells/well with plasmid 
encoding for Spo-20 GFP PA probe (Zhang, 2014). Cells were then serum starved in Phenol 
free-RPMI (0.5%, FBS), 1% Glutamax, 1% Pen/Strep, with IFN-γ, no ITS, for 24 h before 
stimulation with EGF (25 ng/ml). Upon EGF stimulation, cells were fixed at 4% PFA for 10 min 
and then washed with PBS. Following this, YAMC cells were incubated with glycine (100 mM) 
for another 10 min and then washed again with PBS. Last, cells were mount on Prolong Gold 
mounting medium. The positive control cells were transfected and fixed YAMC cells with no 
EGF stimulation. Microscope images were taken at 40X magnification in select fixed cells.  
 
Sw48 K-Ras G12D Cells – Spo-20 GFP PA Probe 
Sw48 K-Ras G12D cells were transfected at a density of 25,000 cells/well with plasmid 
encoding for Spo-20 GFP PA probe (Zhang, 2014). Cells were then serum starved in Phenol 
free-RPMI (0.5%, FBS), 1% Glutamax, 1% Pen/Strep, with IFN-γ, no ITS, for 24 h before 
stimulation with EGF (25 ng/ml). Microscope images were taken at 40X magnification every 1 
min over a 30 min time frame. EGF was directly added to the dish 10 min after the first image 
was acquired. Unlike YAMC cells, this human cancer cell line was in vitro and in vivo. 
Translocation of the Spo-20 GPF PA probe to the plasma membrane was analyzed according to 
the protocol of Feng, 2014 et al12.  
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YAMC Cells – Ras-Raichu FRET Biosensor  
YAMC cells were seeded at a density of 25,000 cells	  into MatTek (Ashland, MA) glass bottom 
35mm dishes and transfected with plasmid encoding for the K-Ras domain targeted KRas-
Raichu (Raichu-124x) biosensor (Mochizuki, 2001). Cells were then serum starved in Phenol 
free-RPMI (0.5%, FBS), 1% Glutamax, 1% Pen/Strep, with IFN-γ, no ITS, for 24 h before 
stimulation with EGF (25 ng/ml), and images were taken at 40X magnification every 2 min over 
a 26 min time frame.  EGF was directly added to the dish 10 min after the first image was 
acquired.  Images were processed with NIS Elements software and FRET ratios between 3 and 
4.5 were	  determined as described previously (Aoki, 2009). Briefly, cells were imaged every two 
minutes, with a Nikon TE 300 Nikon Eclipse fluorescent microscope equipped with a 
programmable XY stage.  The FRET image was acquired by detecting YFP signal during CFP 
excitation. The FRET image was then divided by the corresponding CFP image to generate 
FRET/CFP images used for visualization purposes. Quantification of Ras activation was 
determined by dividing the average FRET signal by the average CFP signal on a per cell basis.  
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CHAPTER III 
RESULTS 
 
Validation of the Spo-20 GFP PA binging probe 
YAMC cells – Spo-20 GFP PA binging probe 
Young adult mouse colonocytes transfected with the Spo-20 GFP PA probe and stimulated with 
EGF did not express significant changes compared to the non-EGF-stimulated cells (control). 
There was no clear translocation of the PA-binding probe to the plasma membrane, as shown in 
Figure 2. Prior scientific studies have described a rapid translocation of the PA-binding probe to 
the plasma membrane within 1 min of EGF stimulation, reaching maximal levels at 3 min 
(Figure 2). However, in this study, this process was not observed over time.  
 
Validation of the probe Spo-20 GFP PA was not successful in YAMC cells, and hence, 
measurement of PA levels in EGF-stimulated cells were not going to be feasible for this study. 
Some possible identified problems include the flattened shape of YAMC cells, a morphological 
factor that affects the ability to differentiate the cytosol from the plasma membrane; the 
microscope resolution might not have been high enough to distinguish cellular cytosol from the 
plasma membrane; the affinity of the Spo-20 GFP may be lacking; and human errors. An 
alternative approach will be to utilize a FRET based biosensor capable of determining PA levels 
(Nishioka, 2010). 
 
 
 
10 
	  
Sw-48 K-Ras G12D cells - Spo-20 GFP PA binging probe 
Sw-48 K-Ras G12D human colon cancer cells were selected as an alternative approach to 
validate the Spo-20 GFP probe primarily for their rounded shape (Figure 1), and malignant 
transformation phenotype. Similar to the YAMC cells results (described above), transfected 
human cancer cells did not exhibit PA-binding probe translocation to the plasma membrane after 
stimulation with EGF compared to non-EGF- stimulated cells (control), as shown in Figure 2. 
The expected immediate plasma membrane localization of the Spo-20 GFP PA probe within 1 
min of EGF stimulation with maximal levels at 3 min was not observed (Figure 2).  These 
findings lead us to conclude that validation of the probe Spo-20 GFP PA was not successful in 
Sw-48 K-Ras G12D. Similar to YAMC cells, there was no translocation of the PA-binding probe 
to the plasma membrane in the Sw48 K-Ras G12D cell model. Plausible problems related to the 
lack of translocation of the PA-binding probe include lack of research evidence of K-Ras 
activation reduction on Sw48 K-Ras G12D cells pre-treated with DHA and EGFR stimulated; 
mutation on the K-Ras domain of Sw48 K-Ras G12D cells, which suggests that the phospholipid 
second messenger, PA is not involved in the activation of K-Ras; low efficiency of the selected 
PA-binding probe, Spo-20 GFP PA; and human errors.  
 
PLD2 and DGK Inhibitor Effects on Transfected YAMC Cells 
For analysis purposes, all of the data obtained in the experiments were compared to the positive 
control, i.e., YAMC cells stimulated with EGF and no inhibitors. According to previous studies 
in the Chapkin Lab, YAMC cells stimulated with EGF generate a rapid peak FRET ratio after 10 
min of imaging (experiment 2). Mr. Robert Fuentes, a graduate student working in the Chapkin 
Lab, observed a peak FRET ratio of over 1.4 increase (Figure 3). However, during this 
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experiment, YAMC cells with EGF and no inhibitors expressed a FRET ratio increase delay of 5 
min (experiment 1). Errors must have occurred when adding EGF to non-treated YAMC cells 
under the microscope. Therefore, these data were excluded from the analysis. The high FRET 
ratio of the positive control seen in cells transfected with the K-Ras Raichu probe is represented 
by red fluorescence as shown in Figure 4. 
 
As mentioned above, the Chapkin Lab has demonstrated that DHA attenuates signaling of the 
Ras-EGFR-MAPK axis in YAMC cells9. Figure 5 indicates that DHA reduced the activation of 
K-Ras represented as demonstrated by a reduction in the FRET ratio levels in EGF stimulated 
cells. With regard to EGF stimulated cells (positive control), DHA suppression of K-Ras was 
assessed relative to YAMC cells treated with inhibitors (Figure 5).  In comparison, YAMC cells 
pre-treated with FIPI (PLD inhibitor) followed by stimulation with EGF exhibited a significant 
(P<0.005)	  decrease in K-Ras activation as represented by the low FRET ratio expression after 10 
min of imaging. From a quantitative perspective, the K-Ras Raichu probe fluorescence levels 
were reduced by approximately 40 % as shown in Figure 6.  
 
YAMC cells pre-treated with DGKi and stimulated with EGF exhibited a blunted increase in the 
FRET ratio compared to EGF alone (positive control) treated cells. (Figure 6). These findings 
suggest that both PLD2 and DGK play a pivotal role in activating K-Ras in the presence of EGF. 
Even though both enzymes are independently regulated, their inhibition generated similarly 
reduced FRET ratios over time.  
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With regard to co-treatment with DGKi and FIPI inhibitors, YAMC cells responded similarly to 
previous treatments, yet after 6 min of EGF simulation, cells expressed a lower FRET ratio value 
that was maintained over time (Figure 6). Examination of the FRET slope for cells treated with 
both inhibitors revealed a noticeable decrease of K-Ras activation in comparison with the 
addition of independent inhibitors. In addition, 10 min following YAMC stimulation with EGF, 
there was a modest and steady drop of the FRET ratio similar to the DHA K-Ras suppression in 
YAMC cells. These findings suggest that inhibition of both PLD2 and DGK generated a greater 
dampening effect on K-Ras (Figure 6). It is noteworthy that some cells pre-incubated with 
inhibitors died upon EGF stimulation (data not shown). These cells were excluded from the 
analysis.  
 
 
Figure	  1.	  Morphology	  of	  YAMC	  cells	  and	  Sw-­‐48	  K-­‐Ras	  G12D	  cells.	  YAMC	  cells	  have	  a	  flattened	  oval	  shape.	  Human	  
colon	  cancer	  cells	  exhibit	  a	  more	  rounded	  shape.	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Figure	  2.	  Validation	  of	  the	  Spo-­‐20	  GFP	  PA	  Probe.	  A)	  HCC1806	  breast	  cancer	  cell	  images	  demonstrate	  a	  noticible	  
plasma	  membrane	  localization	  of	  the	  Spo-­‐20	  GFP	  Pa	  probe12.	  B)	  YAMC	  cells	  expressed	  no	  clear	  membrane	  
localization	  by	  the	  PA-­‐binding	  probe.	  These	  two	  images	  represent	  the	  control	  and	  EGF-­‐stimuted	  cells.	  C)	  Sw-­‐48	  K-­‐
Ras	  G12D	  human	  cancer	  cells	  showed	  no	  translocation	  of	  the	  Spo-­‐20	  GFP	  PA	  probe	  to	  the	  plasma	  membrane.	  
These	  two	  cell	  images	  were	  taken	  from	  cultures	  stimulated	  with	  EGF	  after	  10	  min	  of	  imaging.	  
 
 
Figure	  3.	  EGF	  activates	  K-­‐Ras.	  YAMC	  cells	  stimulated	  with	  EGF	  exhibited	  a	  delayed	  K-­‐Ras	  activation	  response	  
(experiment	  1).	  Research	  studies	  indicate	  that	  K-­‐Ras	  activation	  should	  be	  instantaneous,	  within	  1	  min	  following	  the	  
addition	  of	  EGF	  (experiment	  2).	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Figure	  4.	  YAMC	  cells	  transfected	  with	  a	  K-­‐Ras	  Raichu	  probe.	  A)	  Non-­‐EGF-­‐stimulated	  cells	  with	  no	  inhibitors	  did	  not	  
express	  FRET	  fluorescence	  (pseudo	  colored	  purple).	  B)	  Cells	  with	  no	  inhibitors	  and	  stimulated	  with	  EGF	  (positive	  
control)	  expressed	  high	  red	  fluorescence	  expression	  in	  the	  FRET	  ratio	  scale.	  This	  indicates	  “high”	  K-­‐Ras	  activation.	  
C)	  YAMC	  cells	  pre-­‐treated	  with	  FIPI	  (PLD2	  inhibitor)	  and	  stimulated	  with	  EGF	  expressed	  little	  fluorescence.	  D)	  The	  
FRET	  fluorescence	  signature	  of	  YMAC	  cells	  pre-­‐treated	  with	  DGKi	  (DGK	  inhibitor)	  was	  similar	  to	  FIPI	  treated	  cells.	  E)	  
Pre-­‐treated	  cells	  with	  combined	  FIPI	  &	  DGKi	  and	  EGF	  generated	  the	  lowest	  fluorescence	  FRET	  signature	  compared	  
to	  the	  individual	  inhibitor	  treatments.	  
	  
	  
	  
 
Figure	  5.	  DHA	  suppresses	  K-­‐Ras	  activation.	  Prior	  research	  on	  YAMC	  cells	  has	  shown	  that	  DHA	  attenuates	  K-­‐Ras	  
activation	  following	  stimulation	  with	  EGF	  for	  10	  min9.	  YAMC	  cells	  with	  no	  EGF,	  serves	  as	  a	  negative	  control.	  DHA	  
reduced	  K-­‐Ras	  activation	  by	  approximately	  50%	  after	  4	  min	  of	  EGF	  stimulation	  (P<0.005).	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Figure	  6.	  FIPI	  and	  DGKi	  suppress	  K-­‐Ras	  activation.	  FIPI	  inhibitor	  disrupted	  the	  EGFR-­‐MAPK	  signaling	  pathway	  and	  
reduced	  K-­‐Ras	  activation.	  The	  inhibition	  was	  slow	  and	  constant	  over	  time.	  The	  DGK	  inhibitor	  also	  suppressed	  K-­‐Ras	  
activation.	  Although	  the	  observed	  reduction	  was	  slightly	  greater	  than	  FIPI,	  the	  DGK	  FRET	  ratio	  slope	  eventually	  
reached	  the	  same	  slope	  as	  FIPI.	  	  This	  finding	  suggests	  equivalent	  reduction	  in	  K-­‐Ras.	  FIPI	  and	  DGKi	  combination	  
exhibited	  a	  greater	  K-­‐Ras	  compared	  to	  the	  independent	  respective	  treatment	  (P<0.05).	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CHAPTER IV 
CONCLUSION 
 
Validation of the Spo-20 GFP PA probe 
The validation of the Spo-20 GFP PA probe in both YAMC and Sw48 K-Ras G12D cells was 
not successful due to multiple possible factors, including cell morphological shape, microscope 
resolution, Spo-20 GFP PA suitability, lack of relevant evidence on human cancer cells for this 
study, and human errors. Nonetheless, based on the multiple experimental trials to validate the 
Spo-20 GFP PA probe12, we believe that the efficacy and efficiency of this PA-binding probe 
needs to be re-evaluated. The Spo-20 GFP PA might not be effective, so selecting an alternative 
PA-binding probe is recommended for future DHA-PA related studies. One suggestion is to 
utilize the FRET biosensor for PA named Pii.  This probe contains a lipid-binding domain 
sandwiched with the cyan fluorescent protein and yellow fluorescent protein and is tagged with 
the plasma membrane-targeting sequence of K-Ras19. The use of this FRET-based PA probe 
might afford greater affinity for PA and better results since this PA biosensor binds to cells’ 
plasma membrane. For this study, the K-Ras Raichu probe and the inhibitors FIPI and DGKi 
were adopted as an alternative approach to address the initial hypothesis.  
 
PLD2 and DGK Inhibitor Effects on Transfected YAMC Cells 
Signaling by EGFR is up-regulated in many colon cancer cells12. This process involves two 
critical PA-generating enzymes (PLD2 and DGK) for the activation of K-Ras, a G protein that 
promotes cell growth and proliferation. Data from the present study demonstrated the effects of 
PLD2 and DGKi on K-Ras inhibition.  In general, YAMC cells pre-treated with FIPI (PLD2 
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inhibitor) and/or DGKi exhibited a similar effect on K-Ras activation. Overall, the co-treatment 
(FIPI & DGKi) resulted in the greatest K-Ras reduction as represented by the lowest FRET ratio. 
Interestingly, the FRET ratio data analysis showed that DHA exhibited a similar suppressive 
effect on K-Ras activation.  
 
PLD2 and DGK are enzymes that produce phosphatidic acid in response to an actived EGFR-
MAPK signaling pathway. This signaling pathway then recruits SOS, a guanine nucleotide 
exchange factor that activates Ras9. Since PA is the product of PLD2 and DGK, our findings 
suggest that PA is pivotal for SOS recruitment following activation of K-Ras. Further studies are 
needed in order to determine precisely how PA levels affect Ras activation in YAMC cells. If PA 
is correlated with K-Ras inhibition, this experiment will open a new window into DHA-PA 
related studies for cancer prevention.  
 
The purpose of this study was to demonstrate the relationship between PA-producing enzymes 
and K-Ras activation. However, the initial hypothesis which involved DHA as the extrinsic 
factor responsible for PA attenuation and subsequent K-Ras reduction still needs to be studied. 
Cell viability experiments using YAMC cells treated with DHA, FIPI, DGKi and FIPI & DGKi 
are ongoing. In addition, it is critical that intracellular PA levels be measured using the PA-
binding probe Spo20-GFP-PA (or probes with a greater binding affinity for PA) in combination 
with total internal reflection fluorescence (TIRF) microscopy.   
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APPENDIX A 
CULTURING PROTOCOLS 
 
YAMC Cell Culture: Seeding and Passaging 
 
Purpose: To pass and seed YAMC cell culture. 
 
Preparation:  
 Use sterile hood conditions for the procedure. 
Warm 50 ml of complete RPMI 1640 and 5 ml of trypsin-EDTA (Gibco #25300-054) to 
room temperature. 
 
Procedure:  
For any 70% confluent cell culture in a T-75 flask: 
1.   Add 50 ml of complete media plus 5 µl γ-IFN to a 50 ml conical tube (to grow cells). 
2.   Add 5 ml of Trypsin-EDTA to a 15 ml conical tube. 
3.   Warm both media and trypsin in water bath at 37°C. 
4.   Aspire old media from flask with YAMC cells. 
5.   Rinse monolayer of cells with ∼10 ml HBSS (Sigma, H-6648) by adding and aspiring 
gently without disturbing the cell monolayer.  
6.   Add 5 ml Trypsin-EDTA to the flask and incubate cells at 37°C for 5 minutes. Gently tap 
the bottom of the flask to assist in cell lifting. 
7.   Add 10 ml complete media (step 1) from the conical tube to the flask of trypsinized cells 
to neutralize trypsin (add by rapidly dispensing the media and moving the pipette in a 
back and forth motion across the flask to dislodge any stuck cells).  
8.   Transfer trypsinized cells into a 15 ml conical tube to spin down cells.  
9.   Centrifuge the cells in the tube at 200 x g in the tabletop centrifuge for 5 minutes. 
10.  Use a pipette to transfer 10 µl of the cell suspension onto each end of the hemacytometer. 
Count the number of cells. 
11.  Add 5 ml of complete RPMI 1640 (with γ-IFN) and resuspend the pellet by gently 
pipetting up and down to make a homogenous suspension. It is recommended to gently 
tap the “almost dry” pellet before resuspending with medium to help resuspension.  
12.  Seeds cell according to desired density in complete RPMI 1604 with γ-IFN. Remember to 
open all flasks and dishes under the sterile hood.  
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Sw48 K-Ras G12D Cell Culture: Seeding and Passaging 
 
Purpose: To pass and seed Sw48 K-Ras G12D cell culture. 
 
Preparation:  
 Use sterile hood conditions for the procedure. 
Warm 50 ml of complete RPMI 1640 and 5 ml of trypsin-EDTA (Gibco #25300-054) to 
room temperature. 
 
Procedure:  
For any 70% confluent cell culture in a T-75 flask or T-175 flask: 
1.   Add 50 ml of complete media to a 50 ml conical tube (to grow cells). 
2.   Add 5 ml of Trypsin-EDTA to a 15 ml conical tube. 
3.   Warm both media and trypsin in water bath at 37°C. 
4.   Aspire old media from flask with YAMC cells. 
5.   Rinse monolayer of cells with ∼10 ml HBSS (Sigma, H-6648) by adding and aspiring 
gently without disturbing the cell monolayer.  
6.   Add 5 ml Trypsin-EDTA to the flask and incubate cells at 37°C for 5 minutes. Gently tap 
the bottom of the flask to assist in cell lifting. 
7.   Add 10 ml complete media (step 1) from the conical tube to the flask of trypsinized cells 
to neutralize trypsin (add by rapidly dispensing the media and moving the pipette in a 
back and forth motion across the flask to dislodge any stuck cells).  
8.   Transfer trypsinized cells into a 15 ml conical tube to spin down cells.  
9.   Centrifuge the cells in the tube at 200 x g in the tabletop centrifuge for 5 minutes. 
10.  Use a pipette to transfer 10 µl of the cell suspension onto each end of the hemacytometer. 
Count the number of cells. 
11.  Add 5 ml of complete RPMI 1640 and resuspend the pellet by gently pipetting up and 
down to make a homogenous suspension. It is recommended to gently tap the “almost 
dry” pellet before resuspending with medium to help resuspension.  
12.  Seed cells according to desired density in complete RPMI 1604. Remember to open all 
flasks and dishes under the sterile hood.  
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APPENDIX B 
TRANSFECTION PROTOCOLS 
 
YAMC Cell Culture: Transfection 
 
Purpose: To transfect YAMC cells. 
 
Preparation:  
Use sterile hood conditions for the procedure. 
Warm 10-30 ml of complete RPMI at room temperature depending on needed media.  
 
DNA-lipid Complex Preparation:  
1.   Add 4 µl of Lipofectamine 3000 plus 250 µl of Opti-MEM Medium into a 1.5 ml conical 
tube. These amounts are base in a single dish or well.  
2.   Add 5 µl of P3000 Reagent, 250 µl of Opti-MEM Medium, and 2 µg of DNA into a 1.5 
ml conical tube. These amounts are based in a single dish or well. 
3.   Transfer the Lipofectamin 3000 and Opti-MEM Medium solution (step1) into the P3000 
reagent containing solution.  
 
Procedure: 
Fro any 70%-90% confluent cell culture: 
1.   Seed 25,000 to 35,000 cells in a 35 mm dish. 
2.   Warm needed media with γ-IFN.  
3.   Aspire old media from dishes or wells with YAMC cells. 
4.   Rinse monolayer of cells with ∼2 ml HBSS (Sigma, H-6648) by adding and aspiring 
gently without disturbing the cell monolayer.  
5.   Add between 1.6 – 1.9 ml of new complete RPMI media with γ-IFN to each dish or well 
6.   Add the respective calculated amount of DNA complex to each dish or well.  
7.   Incubate cells at 37°C.  
 
 
 
 
 
Sw48 K-Ras G12D Cell Culture: Transfection 
 
Purpose: To transfect Sw48 K-Ras G12D cells. 
 
Preparation:  
Use sterile hood conditions for the procedure. 
Warm 10-30 ml of complete RPMI at room temperature depending on needed media.  
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DNA-lipid Complex Preparation:  
1.   Add 4 µl of Lipofectamine 3000 plus 250 µl of Opti-MEM Medium into a 1.5 ml conical 
tube. These amounts are base in a single dish or well.  
2.   Add 5 µl of P3000 Reagent, 250 µl of Opti-MEM Medium, and 2 µg of DNA into a 1.5 
ml conical tube. These amounts are based in a single dish or well. 
3.   Transfer the Lipofectamin 3000 and Opti-MEM Medium solution (step1) into the P3000 
reagent containing solution.  
 
Procedure: 
For any 70%-90% confluent cell culture: 
1.   Seed 25,000 to 35,000 cells in a 35 mm dish. 
2.   Warm needed media.  
3.   Aspire old media from dishes or wells with YAMC cells. 
4.   Rinse monolayer of cells with ∼2 ml HBSS (Sigma, H-6648) by adding and aspiring 
gently without disturbing the cell monolayer.  
5.   Add between 1.6 – 1.9 ml of new complete RPMI media to each dish or well. 
6.   Add the respective amount of DNA-lipid complex to each dish or well.  
7.   Incubate cells at 37°C.  
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APPENDIX C 
CELL FIXATION PROTOCOL 
 
YAMC Cell Culture: Transfection 
 
Purpose: To fix YAMC cells. 
 
Procedure: 
1.   Make 4% PFA at room temperature. Dilute reagents in PBS. This must be done in the 
chemical hood. Always make PFA fresh (i.e. the same day of the experiment). Dilute 
20% PFA 1:5 and 8% GA 1:80. 
2.   Aspire media and rinse with PBS, then immediately add 500 µl PFA (4%) per well for 10 
minutes at room temperature. This must be done in the chemical hood.   
3.   Rinse the samples with 2 ml of PBS 3 times each, and incubate cells with 500 µl glycine 
(100 mM) in PBS for 10 min at room temperature. This step is performed to quench 
aldehyde groups. Do first wash in chemical hood and dump into waste. 
4.   Wash with PBS twice to remove any residual glycine. 
5.   Use tool to remove plastic cover. 
6.   Add ∼3 drop antifade reagent with DAPI. Make sure it coats the sample with the light 
layer.  
7.   Place lid on samples then cover with foil and allow to cure for 24 hours in the dark.  
8.   After curing, seal with clear nail polish and the samples can be stored at 4°C. 
 
 
 
 
 
 
